An observational study in Haemostasis Embolisation, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-27.
Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Observational
NBCA is a synthetic biodegradable cyanoacrylate basis glue, modified by the addition of a monomer with adhesive, hemostatic, and antiseptic properties.
Its use requires a steep learning curve to control emulsification of the NBCA/lipiodol mixture, and injection, to avoid non-target embolization.
The aim of this retrospective monocentric study was to evaluate safety and efficacy of use of NBCA as embolic agent in emergency setting.
1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.
This study's enrollment of 122 is below the median of 353 across 714 observational studies indexed under Emergencies.
Browse Emergencies studies →Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 578 studies on the registry; 128 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients treated by TAE with NBCA, based on clinical decisions in emergency and CT scan.
Exclusion Criteria:
All patients referred to our hospital and treated by TAE with NBCA, based on clinical decisions in emergency and CT scan.
Other: Clinical data · Other: Imaging data · Other: Biological data
Collecting data from the medical record.
Collecting data from the medical record.
Collecting data from the medical record.
Evaluation of technical success
Analysis of angiographic results.
Time frame: Month : 1
Assessment of clinical success
Disappearance of signs and symptoms of bleeding during the 30 days of follow-up after WT
Time frame: Month : 1
Assessment of clinical success
No endoscopic treatment
Time frame: Month : 1
Assessment of clinical success
No surgical intervention
Time frame: Month : 1
Assessment of clinical success
No repeat WT
Time frame: Month : 1
Assessment of clinical success
Absence of death due to massive blood loss
Time frame: Month : 1
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Saint Etienne